Report Details:
15 Companies Covered
200 Pages
Market Overview
Brain Monitoring Market Devices Market Size was estimated at 6.25 USD Billion in 2024. The Brain Monitoring Market Devices industry is projected to grow from 6.535 USD Billion in 2025 to 10.21 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.56% during the forecast period 2025 - 2035.
Brain monitoring is a complex process involved in assessing functioning of the brain, which can be disrupted by a number of factors such as congenital defects, infections and trauma. The rising incidence of neurological disorders such as stroke, depression, Parkinson’s, dementia and cerebral palsy has prompted market players to develop technologies that are more complex and cost effective. Growing demand for effective care & treatment of neurologically damaged patients is driving the growth of the global brain monitoring market.
Carbon dioxide monitoring is gaining popularity as a brain function monitoring device. This device is designed to detect early changes in carbon dioxide levels with the combination of deep or dynamic monitoring. The increasing demand for minimally invasive neurological procedure is creating new opportunities for the development of brain monitoring technology.
In addition, advancement in brain monitoring technology is anticipated to bring about significant improvement in the accuracy, capacity and convenience of the process. Moreover, it is anticipated that this factor will boost the growth of the worldwide brain monitoring market over the forecast period.
Additionally, rising research activities in the field of neuroscience and growing R&D expenditure by government & private organizations are contributing to the market growth.However, lack of expertise and fewer number of qualified specialist may impede the market growth over the forecast period.
Market Segmentation
The global brain monitoring market has been segmented based on product & service, type, application and end-user.Based on type, the global brain monitoring market has been segmented into intracranial pressure (ICP) monitoring, electroencephalography (EEG) monitoring, transcranial doppler (TCD) monitoring, magnetoencephalography (MEG) monitoring and electromyography (EMG) monitoring.
The EEG monitoring segment holds the largest market share and is also expected to be the fastest-growing segment during the forecast period.The global market for brain monitoring has been split into product and service categories. The product category is subdivided into devices and accessories.
The services segment is subdivided into managed services and professional services.The global market for brain monitoring has been divided based on application into addiction, sleep disorder, attention-deficit disorder, neurological disorder, and monitoring. The monitoring segment holds the biggest market share and is anticipated to increase at the highest rate throughout the forecast period.
Regional Report Analysis
The global market for brain monitoring has been analyzed in terms of five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.During the projected period, North America is anticipated to dominate the worldwide brain monitoring market.
This growth can be attributed to the presence of significant number of market players in the region and their presence in research and development activities. In addition, improving healthcare infrastructure, rising healthcare spending and technological advancements are fuelling the growth of the market in the region.
The Asia-Pacific brain monitoring market is anticipated to be the fastest-growing region over the forecast period. This growth can be attributed to the rapid growth of healthcare industry, surge in the number of hospitals and development of pediatric care services in the region.
Over the forecast period, the market for brain monitoring in Europe is anticipated to exhibit somewhat stable growth. The market in Europe is also expected to benefit from several government initiatives such as Collaborative Project on Clinical Brain Monitoring in Europe and European Imaging in Parkinson’s Disease (EIPD).
Competitive Landscape
The major players operating in the global brain monitoring market are Avadel Pharmaceuticals plc (Republic of Ireland), Natus Medical Incorporated (US), Nihon Kohden Corporation (Japan), SIGMA Medizin-Technik GmbH & Co KG (Germany), Compumedics Limited (Australia), Advanced Brain Monitoring (US), CAS Medical Systems, Inc. (US), Medtronic plc (Republic of Ireland), NeuroWave Systems, Inc. (US) and uralytics GmbH (Germany).
Industry/Innovation/Related NewsJune 2019 – The FDA approved a new neuromonitoring device by Medtronic plc for patients undergoing vertebral augmentation procedures for treatment of spinal abnormalities. The device is the first non-bone-conducted acoustic neural monitoring system cleared by FDA.
